Dr.Reddy's Laboratories Ltd (NYSE:RDY)
During the Trading Day
| 36.71 |  -0.27 / -0.73% |
Data as of 4:04pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 36.72 |  +0.0085 / +0.02% |
Volume: 3.7K |
Latest RDY News | Press Releases
| Label Expansion for Astellas Drug - Analyst Blog Jun 17 / Zacks.com | Dr. Reddy's and Fujifilm End JV - Analyst Blog Jun 04 / Zacks.com |
Today’s Trading
| Previous close | 36.98 |
| Today’s open | 36.29 |
| Day’s range | 36.29 - 36.80 |
| Volume | 147,962 |
| Average volume (3 months) | 229,372 |
| Market cap | $6.3B |
| Dividend yield | 0.67% |
Data as of 4:04pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | +13.21% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +5.31% |
| P/E ratio | -- |
| Price/Sales | 2.57 |
| Price/Book | 4.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PCYCPharmacyclics Inc | +1.07 | +1.23% |
| HSPHospira Inc | +0.17 | +0.47% |
| ONXXOnyx Pharmaceuticals... | -1.18 | -1.31% |
| ELNElan Corporation PLC | +0.29 | +2.15% |
Data as of 4:02pm ET, 06/18/2013
Financials
| Next reporting date | July 22, 2013 |
| EPS forecast (this quarter) | $0.47 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $308.2M |
| Net profit margin | 14.43% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
Chairman & Chief Executive Officer Gunupati Venkateswara Prasad |
Vice Chairman, MD & Chief Operating Officer Kallam Satish Reddy |
Corporate headquarters Hyderabad, Andhra Pradesh |
Forecasts
